Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines. (Q40979868)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Giorgio Walter Canonica

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

F Paolieri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Battifora

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

C Bertolini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Cutolo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Bloom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G Ciprandi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Bagnasco

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 December 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

81

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

601-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

Adhesion molecules of allergic inflammation: recent insights into their functional roles.

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Future drug therapy for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Terfenadine reduces skin and conjunctival reactivity in grass pollen allergic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Terfenadine. An updated review of its pharmacological properties and therapeutic efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Antiallergic effects of terfenadine on immediate type hypersensitivity reactions.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Inhibitory effect of terfenadine on mediator release from human blood basophils and eosinophils

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Antiallergic activity of H1-receptor antagonists assessed by nasal challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

A possible role for adhesion molecules in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Bronchial biopsies in asthma. An ultrastructural, quantitative study and correlation with hyperreactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Adhesion molecules and their role in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Deflazacort protects against late-phase but not early-phase reactions induced by the allergen-specific conjunctival provocation test

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Ocular challenge and hyperresponsiveness to histamine in patients with allergic conjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Protective effect of different doses of terfenadine on the conjunctival provocation test.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

The pharmacology and mechanisms of action of histamine H1-antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Circulating adhesion molecules in disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

Histamine and cardiac arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962712-3

7 January 2021

10.1016/S1081-1206(10)62712-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9892033%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference